CIRC advances isotope separation, expands nuclear cooperation with Brazil
China Isotope & Radiation Corp (CIRC) has announced the launch of a new "Adsorption Trapper" isotope separation technology. Developed by its subsidiary Chengdu Gaotong Isotope Co., Ltd. (CNGT), this fourth-generation MOF material-based technology aims to advance nuclear medicine and controlled nuclear fusion. It offers high purity, efficiency, and low cost, and is expected to bolster China's independent isotope supply chain and reduce reliance on high-end isotope imports.
Concurrently, CIRC expanded its international collaborations by signing a Memorandum of Understanding on Cooperation in Isotope Procurement with the Brazil National Commission for Nuclear Energy (CNEN). This agreement, signed at the 30th IAEA Fusion Energy Conference, establishes a long-term mechanism for cooperation in isotope supply, quality management, information exchange, and joint R&D to support Brazil's nuclear technology and radiopharmaceutical industries.
Both announcements, dated October 17, 2025, highlight CIRC's strategic efforts to enhance its technological capabilities and expand its global footprint in the peaceful uses of nuclear technology and public health. The board of directors, led by chairman Xiao Yafei, continues to oversee these developments.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when China Isotope & Radiation Corp publishes news
Free account required • Unsubscribe anytime